$18.70
-0.2-1.06%
Last update: 3:23 PM
15 minutes delayed
Comments
Loading...
Medifast (NYSE:MED) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Medifast (MED)?
The most recent guidance for Medifast (MED) was reported on August 5, 2024 for Q3 2024. The company provided earnings per share guidance in the range of $-0.70 to $-0.05, compared to the estimated EPS of $-0.52. Additionally, Medifast forecasted revenue between $0.13B and $0.14B for the quarter.
Browse guidance and forecast on all stocks.